BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 12366429)

  • 21. CD5 negative lymphocytosis mimicking typical B-chronic lymphocytic leukaemia. Description of 26 cases.
    De Rossi G; Mauro FR; Lo Coco F; Caruso R; Niscola P; Pasqualetti D; Mandelli F
    Nouv Rev Fr Hematol (1978); 1993 Aug; 35(4):451-5. PubMed ID: 7692397
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic lymphocytic leukaemia skin infiltrates affecting prominent parts of the face and the scalp.
    Jasim ZF; Cooke N; Somerville JE; Hay RJ
    Br J Dermatol; 2006 May; 154(5):981-2. PubMed ID: 16634906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cannabinoid receptors expression in bone marrow trephine biopsy of chronic lymphocytic leukaemia patients treated with purine analogues.
    Piszcz JA; Lemancewicz D; Kloczko J; Dzieciol J; Rusak M; Dabrowska M
    Exp Oncol; 2007 Sep; 29(3):221-5. PubMed ID: 18004250
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD5-negative chronic lymphocytic leukemia with indolent clinical course and autoimmune thrombocytopenia, successfully treated with rituximab.
    Okamoto M; Nakano S; Namura K; Yamada N; Uchida R; Fuchida S; Okano A; Ochiai N; Shimazaki C
    Am J Hematol; 2004 Dec; 77(4):413-5. PubMed ID: 15551407
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral cladribine for B-cell chronic lymphocytic leukaemia: report of a phase II trial with a 3-d, 3-weekly schedule in untreated and pretreated patients, and a long-term follow-up of 126 previously untreated patients.
    Karlsson K; Strömberg M; Liliemark J; Delannoy A; Johnson SA; Porwit A; Kimby E; Lärfars G; Cristiansen I; Nilsson G; Celsing F; Sundström G; Luthman M; Tidefelt U; Wallvik J; Juliusson G
    Br J Haematol; 2002 Mar; 116(3):538-48. PubMed ID: 11849209
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Second malignancies and Richter's syndrome in patients with chronic lymphocytic leukaemia treated with cladribine.
    Robak T; Blonski JZ; Gora-Tybor J; Kasznicki M; Konopka L; Ceglarek B; Komarnicki M; Lewandowski K; Hellmann A; Lewandowski K; Moskwa A; Dmoszyńska A; Sokołowska B; Dwilewicz-Trojaczek A; Tomaszewska A; Sułek K; Całbecka M
    Eur J Cancer; 2004 Feb; 40(3):383-9. PubMed ID: 14746857
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Achieving optimal outcomes in chronic lymphocytic leukaemia.
    Hamblin TJ
    Drugs; 2001; 61(5):593-611. PubMed ID: 11368285
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 2-Chlorodeoxyadenosine (CdA) for patients with previously untreated chronic lymphocytic leukemia (CLL).
    Delannoy A; Martiat P; Gala JL; Deneys V; Ferrant A; Bosly A; Schieff JM; Michaux JL
    Leukemia; 1995 Jul; 9(7):1130-5. PubMed ID: 7630184
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship between the expression of CD25 and CD69 on the surface of lymphocytes T and B from peripheral blood and bone marrow of patients with chronic lymphocytic leukemia and established prognostic factors of this disease.
    Grywalska E; Bartkowiak-Emeryk M; Pasiarski M; Olszewska-Bożek K; Mielnik M; Podgajna M; Pieczykolan M; Hymos A; Fitas E; Surdacka A; Góźdź S; Roliński J
    Adv Clin Exp Med; 2018 Jul; 27(7):987-999. PubMed ID: 29893517
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cladribine in the treatment of chronic lymphocytic leukemia.
    Robak T
    Leuk Lymphoma; 2001 Feb; 40(5-6):551-64. PubMed ID: 11426528
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Leukemia cutis (involving chronic lymphocytic leukemia) within excisional specimens: a series of 6 cases.
    Walther BS; Gibbons G; Chan EF; Ziselman E; Rothfleisch JE; Willard RJ; Baldassano MF
    Am J Dermatopathol; 2009 Apr; 31(2):162-5. PubMed ID: 19318802
    [TBL] [Abstract][Full Text] [Related]  

  • 32. B-cell chronic lymphocytic leukemia associated with high serum IGE levels and pruriginous skin lesions: successful therapy with IFN-alpha 2b after failure on IFN-gamma.
    Neuber K; Berg-Drewniock B; Volkenandt M; Neumaier M; Zeller W; Gross G; Ring J
    Dermatology; 1996; 192(2):110-5. PubMed ID: 8829490
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rituximab therapy in cutaneous infiltration of chronic lymphocytic leukaemia.
    Ramakrishna R; Sarathy K; Sarathy T
    Acta Haematol; 2013; 130(1):47-51. PubMed ID: 23406682
    [No Abstract]   [Full Text] [Related]  

  • 34. Zosteriform B-cell chronic lymphocytic leukemia infiltration.
    Antunes J; Pacheco D; Travassos R; Filipe P
    Dermatol Online J; 2011 Sep; 17(9):9. PubMed ID: 21971274
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of CD23 antigen expression in B-chronic lymphocytic leukaemia and its correlation with clinical parameters.
    Jurisic V; Colovic N; Kraguljac N; Atkinson HD; Colovic M
    Med Oncol; 2008; 25(3):315-22. PubMed ID: 18183502
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Asymptomatic cauliflower ears in a 73-year-old man. Diagnosis: Leukemia cutis in the setting of indolent B-cell chronic lymphocytic leukemia (B-CLL).
    Kim PS; Sheth PB
    Arch Dermatol; 2011 Dec; 147(12):1443, 1448. PubMed ID: 22184770
    [No Abstract]   [Full Text] [Related]  

  • 37. Transient leukaemia cutis in chronic lymphocytic leukaemia.
    Wakelin SH; Young E; Kelly S; Turner M
    Clin Exp Dermatol; 1997 May; 22(3):148-51. PubMed ID: 9425697
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mycosis fungoides and chronic lymphocytic leukaemia--composite T-cell and B-cell lymphomas presenting in the skin.
    Hull PR; Saxena A
    Br J Dermatol; 2000 Aug; 143(2):439-44. PubMed ID: 10951162
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of image analysis and immunostaining of bone marrow trephine biopsy specimens to quantify residual disease in patients with B-cell chronic lymphocytic leukemia.
    Gala JL; Guiot Y; Delannoy A; Scheiff JM; Philippe M; Martiat P
    Mod Pathol; 1999 Apr; 12(4):391-9. PubMed ID: 10229504
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Valproate synergizes with purine nucleoside analogues to induce apoptosis of B-chronic lymphocytic leukaemia cells.
    Bouzar AB; Boxus M; Defoiche J; Berchem G; Macallan D; Pettengell R; Willis F; Burny A; Lagneaux L; Bron D; Chatelain B; Chatelain C; Willems L
    Br J Haematol; 2009 Jan; 144(1):41-52. PubMed ID: 19006566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.